Actively Recruiting
Outcomes of Arthroscopic AMIC Treatment for Osteochondral Lesions of the Talus in Adults Aged 18 to 65
Led by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Updated on 2017-12-13
103
Participants Needed
1
Research Sites
513 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the clinical and imaging results in patients who have undergone an all-arthroscopic autologous matrix induced chondrogenesis AMIC procedure to treat symptomatic osteochondral lesions of the talus bone in the ankle. This study aims to understand the effectiveness of this minimally invasive technique for cartilage repair in this specific joint condition. Participants will receive an arthroscopic treatment where a specialized matrix called Chondro-gide is used to fill the talar osteochondral lesion. This procedure is performed through small incisions using a camera and instruments, focusing on cartilage reconstruction using the AMIC technique. The study does not involve comparison groups or blinding. During the 5-year follow-up, participants will undergo radiologic assessments to measure the reduction of the lesion size and monitor clinical outcomes. Researchers will collect clinical data and imaging results over time to evaluate the healing and functional status of the treated ankle. The total duration of participation includes the initial surgery and a long-term observation period to track improvements and safety.
CONDITIONS
Brief Title
Clinical and Radiographic Outcomes After AMIC Treatment for Talus Osteochondral Lesion Trattamento Artroscopico Delle Lesioni Osteocondrali Dell'Astragalo Con Tecnica AMIC
Research Team
F
Federico G Usuelli, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here